Browsing "Comunicações em Eventos - LIM/60" by Subject Infectious Diseases

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 12 of 12
Issue DateTitleAuthor(s)
2013Antigen Design to Maximize Anti-HIV CD4+T Cell Responses: Provision of Cognate Help, Increased Coverage and Coping with HIV Genetic VariabilityCUNHA-NETO, E.; ROSA, D. S.; RIBEIRO, S.; ALMEIDA, R. R.; SANTANA, V. C.; KALIL, J.
2018Attitudes and Knowledge About HIV PrEP Among Infectious Diseases Physicians in BrazilCERQUEIRA, Natalia; VASCONCELOS, Ricardo; HOJILLA, Carlo; KALLAS, Esper; AVELINO-SILVA, Vivian
2013Broad and Cross-clade CD4+T-Cell Responses Elicited by a DNA Vaccine Encoding Highly Conserved and Promiscuous HIV-1 M-Group Consensus PeptidesALMEIDA, R. R.; ROSA, D. S.; RIBEIRO, S. P.; SANTANA, V. C.; KALLAS, E. G.; SIDNEY, J.; SETTE, A.; KALIL, J.; CUNHA-NETO, E.
2016Cellular Immune correlates Analysis of an HIV-1 Pre-exposure Prophylaxis TrialKUEBLER, Peter; MEHROTRA, Megha; MCCONNELL, Jeff; HOLDITCH, Sara; SHAW, Brian; TAROSSO, Leandro; LEADABRAND, Kaitlyn; MILUSH, Jeffrey; YORK, Vanessa; RAPOSO, Rui Andre Saraiva, et al
2018Comparison of measures of adherence to HIV pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) and transgender women (TGW): results from the PrEP Brasil studyMARINS, L. M. S.; TORRES, T. S.; LEITE, I. Costa; MOREIRA, R. I.; HOAGLAND, B.; KALLAS, E. G.; MADRUGA, J. V.; ANDERSON, P. L.; LIU, A. Y.; GRINSZTEJN, B., et al
2018Extensive local reaction after vaccinationLARA, A. N.; IGNOTO, B.; TABORDA, M.; MARINHO, A. K. B.; MIYAJI, K.; GONCALVES, D. G.; GALASTRI, A.; IBRAHIM, K.; LOPES, M. H.; SARTORI, A. M.
2017High level of retention and adherence at Week 48 for MSM and TGW enrolled in the PrEP Brasil demonstration studyGRINSZTEJN, B.; HOAGLAND, B.; MOREIRA, R.; KALLAS, E.; MADRUGA, J.; LEITE, I.; BONI, R. de; ANDERSON, P.; LIU, A.; LUZ, P., et al
2013HIV CD4 Based Vaccine Increases CD8 T Cell Responses and Confers Protection Against Challenge with Recombinant Vaccinia Encoding HIV Gag-Pol ProteinsRIBEIRO, S. P.; ROSA, D. S.; KALIL, J.; CUNHA-NETO, E.
2018Low prevalence after the first Zika virus epidemic wave in Southeastern BrazilLUNA, E.; ROMANO, C.; ARAUJO, E.; FELIX, A. C.; NAKASONE, O.; CAMPOS, S.; FERNANDES, L.; LEVI, J. E.; SANTIAGO, N.; FERNANDES, J., et al
2015Pre-exposure prophylaxis uptake and associated factors among MSM and TGW in the PrEP Brasil demonstration projectHOAGLAND, Brenda; VELOSO, Valdilea G.; BONI, Raquel B. De; MADRUGA, Jose Valdez; KALLAS, Esper G.; FERNANDES, Nilo Martinez; MOREIRA, Ronaldo I.; LIU, Albert Y.; GRINSZTEJN, Beatriz
2018Retention and Persistance on PrEP for MSM and TGW: 96-week Results of the PrEP Brazil Demonstration StudyVELOSO, Valdilea G.; TORRES, Thiago Silva; MOREIRA, Ronaldo I.; LEITE, Iuri C.; KALLAS, Esper G.; CERQUEIRA, Natalia B.; MADRUGA, Jose V.; GOULART, Silvia P.; FERNANDES, Nilo M.; SANTOS, Tony A., et al
2014Vaccine Antigen Design to Maximize anti-HIV CD4+T-cell Responses: From Mice to Non-human PrimatesCUNHA-NETO, Edecio; RIBEIRO, Susan; SANTORO-ROSA, Daniela; ALMEIDA, Rafael; SANTANA, Vinicius; KALIL, Jorge